Purpose

This research is being done because there is a need to improve cancer risk communication and decision-making among adolescents and young adults. In this study, the investigators are looking at whether using a chatbot and online portal for cancer risk information helps improve communication and decision-making. - Over 70,000 adolescents and young adults (AYAs) are diagnosed with cancer in the U.S. every year and up to 10% have genetic changes (or, mutations) that put them at a higher risk of developing new cancers during their lifetimes. These genetic mutations can result in cancer risk syndromes (such as, Lynch Syndrome or Li-Fraumeni Syndrome). Identifying cancer risk syndromes can allow for screening and early diagnosis of future cancers, which could ultimately save lives and offer more care choices for patients. As a result, genetic counseling and testing for cancer risk syndromes is being recommended more for Adolescents and Young Adults with new cancer diagnoses, regardless of family history. - This research study to develop an intervention called AYA-RISE that aims to assist AYAs with cancer risk communication and decision-making around their caregivers.

Condition

Eligibility

Eligible Ages
Between 12 Years and 24 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Criteria

Inclusion Criteria:

- Across all study aims, we will enroll AYA patients, family members/caregivers, and
providers.

AIM 1, PART 1 - STAKEHOLDER INTERVIEWS

AYA Patients

1. Ages 12-24 years, inclusive

2. Diagnosed with a cancer risk syndrome

3. English-speaking and -reading

4. Receiving care at any of the study sites OR participating in the LiFraumeni Syndrome
Association (LFSA) Youth Conference

5. Adequate cognitive function per NeuroQOL indicated by a score of 30 or greater

6. Not receiving active cancer therapy

Family caregivers-Inclusion Criteria

1. Parent/guardian, spouse/partner, or other family member who participates in the care
of AYAs aged 12-24 with cancer risk syndromes

2. English-speaking and -reading

3. At any of the study sites

Providers Inclusion Criteria (Oncologists, nurses, genetic counselors, social workers, or
psychologists)

1. English-speaking and reading

2. Caring for AYAs aged 12-24 with cancer risk syndromes at any of the study sites

AIM 1, PART 2 - INTERVENTION PILOT

AYA Patients

1. Ages 12-24 years, inclusive

2. Diagnosed with a cancer risk syndrome

3. English-speaking and -reading

4. Receiving care at Dana-Farber Cancer Institute

5. Adequate cognitive function per NeuroQOL, indicated by a score of 30 or greater

6. Not receiving active cancer therapy

7. Did not participate in a stakeholder interview

Eligibility notes:

- Family caregivers of participating 12-17y patients will be eligible to participate
in the pilot

- 12-17y patients can participate without a family member if both the patient and
family member agree.

- Patients 18-24y will have the option to participate with or without a family member.

AIM 2 - RANDOMIZED TRIAL

AYA Patients

1. Ages 12-24 years, inclusive

2. Diagnosed with a cancer risk syndrome

3. English-speaking and reading

4. Has a planned post-disclosure genetic counseling or follow-up visit at any of the
study sites

5. Adequate cognitive function per NeuroQOL, indicated by a score of 30 or greater

6. Not receiving active cancer therapy

7. Did not participate in either part of Aim 1 (interview or pilot)

Family caregivers

1. Parent/guardian, spouse/partner, or other family member who participates in the care
of AYAs aged 12-24 with cancer risk syndromes

2. English-speaking and -reading

3. At any of the study sites

4. Did not participate in either part of Aim 1 (interview or pilot)

AIM 3 - SEMI-STRUCTURED INTERVIEWS AYA Patients, Family Caregivers, Providers, and Site
PIs

1. Participated in the intervention arm of Aim 2, or

2. Is a site principal investigator at one of the 4 participating study sites

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Health Services Research
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
No Intervention
Aim 1-Part 1 Stakeholder Interview
This arm will focus on finding the best format for the study intervention (called AYA-RISE) whether AYA-RISE is easy to use; and whether patients, family caregivers, and providers find AYA-RISE acceptable. The research study procedures include: - Using and reviewing AYA-RISE - Participating in audio-recorded, 30-minute interviews
Experimental
Aim 1-Part 2
This arm is a pilot study of the study intervention (called AYA-RISE). The activities involved in this part of the study are: - Baseline Questionnaire - Using and reviewing AYA-RISE - Follow-up Questionnaire - Brief interviews to get feedback on AYA-RISE
  • Behavioral: AYA-RISE Adolescents and Young Adults Risk Information and Screening Education
    A chatbot is a computer program that can chat with humans. The text the chatbot uses to talk with humans was created by real people, but the chatbot itself is not a real person. A company called Clear Genetics developed the original chatbot and patient portal, and this study team customized it for this research study.
    Other names:
    • AYA-RISE
Active Comparator
Aim 2-Genetic Counseling
The names of the study activities involved in this study are: - Baseline Questionnaire - Follow-up Questionnaire - Medical record review The study procedures will all take place on the day of the patient's regularly scheduled clinic visit. Participants will be in this research study for up to 1 year.
  • Behavioral: Standard clinical visit for genetic counseling
    Standard clinical visit for genetic counseling and follow up
Experimental
Aim 2- Genetic Counseling with AYA-RISE
The names of the study activities involved in this study are: - Baseline Questionnaire - Follow-up Questionnaire - Medical record review - Using the study intervention, AYA-RISE The study procedures will all take place on the day of the patient's regularly scheduled clinic visit. Participants will be in this research study for up to 1 year.
  • Behavioral: AYA-RISE Adolescents and Young Adults Risk Information and Screening Education
    A chatbot is a computer program that can chat with humans. The text the chatbot uses to talk with humans was created by real people, but the chatbot itself is not a real person. A company called Clear Genetics developed the original chatbot and patient portal, and this study team customized it for this research study.
    Other names:
    • AYA-RISE
No Intervention
Aim 3 Semi-structured interviews
Each site will conduct 30-minute interviews with patients, caregivers, and providers, and site principal investigators.

Recruiting Locations

Boston Children's Hospital
Boston, Massachusetts 02115
Contact:
Jennifer Mack, MD
617-632-6622
JMACK@PARTNERS.ORG

Dana Farber Cancer Institute
Boston, Massachusetts 02115
Contact:
Jennifer Mack, MD
617-632-6622
JMACK@PARTNERS.ORG

More Details

Status
Recruiting
Sponsor
Dana-Farber Cancer Institute

Study Contact

Jennifer Mack, MD
(617) 632-6622
JMACK@PARTNERS.ORG

Detailed Description

This research study involves three aims (Aims 1, 2, and 3). - Aim 1, Part 1, which focuses on finding the best format for the study intervention (called AYA-RISE); whether AYA-RISE is easy to use; and whether patients, family caregivers, and providers find AYA-RISE acceptable.The research study procedures include: - Using and reviewing AYA-RISE, - Participating in audio-recorded, 30-minute interviews - Aim 1, Part 2, which is a pilot study of the study intervention (called AYA-RISE). In this pilot study, the investigators are looking at whether AYA-RISE is easy to use and what participants think of it. -- The activities involved in this part of the study are: - Baseline Questionnaire - Using and reviewing AYA-RISE - Follow-up Questionnaire - Brief feedback interviews on AYA-RISE - In Aim 2, participants will be randomized trial into one of two groups; - Group 1: Standard Genetic Counseling/follow-up visit or - Group 2 : Standard Genetic Counseling/follow-up visit and Access to AYA-Rise - Aim 3: Semi-Structured Interviews: - Evaluate implementation outcomes using 28 semi-structured interviews with patients, family members, providers, and site principal investigators

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.